A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions

Clinical trial NCT06308679 · UNKNOWN

Trial details

NCT number: NCT06308679
Sponsor: Pharma Nueva
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Vollunteer

Start date: 2024-05-28
Primary completion: 2024-05-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.